BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Qin K, Camacho MV, Cali I, Yuan J, Shen P, Greenlee J, Kong Q, Mastrianni JA, Zou WQ. Generation of human chronic wasting disease in transgenic mice. Acta Neuropathol Commun 2021;9:158. [PMID: 34565488 DOI: 10.1186/s40478-021-01262-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun JL, Telling GC. New developments in prion disease research using genetically modified mouse models. Cell Tissue Res 2023. [PMID: 36929219 DOI: 10.1007/s00441-023-03761-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Smith K, Landon AC, Schroeder SA, Mcinenly LE. Application of the Heuristic-Systematic Model to Chronic wasting Disease Risk perceptions. Society & Natural Resources 2023. [DOI: 10.1080/08941920.2023.2183443] [Reference Citation Analysis]
3 Cook M, Hensley-mcbain T, Grindeland A. Mouse models of chronic wasting disease: A review. Front Virol 2023;3. [DOI: 10.3389/fviro.2023.1055487] [Reference Citation Analysis]
4 Bradford B, Mabbott NA, Diack AB. Transgenic Mice Modelling in Prion Diseases. Prions and Diseases 2023. [DOI: 10.1007/978-3-031-20565-1_15] [Reference Citation Analysis]
5 Priola SA. Species Barriers in Prion Disease. Prions and Diseases 2023. [DOI: 10.1007/978-3-031-20565-1_13] [Reference Citation Analysis]
6 Wang F, Pritzkow S, Soto C. PMCA for ultrasensitive detection of prions and to study disease biology. Cell Tissue Res 2022;:1-15. [PMID: 36567368 DOI: 10.1007/s00441-022-03727-5] [Reference Citation Analysis]
7 Mortberg MA, Minikel EV, Vallabh SM. Analysis of non-human primate models for evaluating prion disease therapeutic efficacy. PLoS Pathog 2022;18:e1010728. [DOI: 10.1371/journal.ppat.1010728] [Reference Citation Analysis]
8 Cassmann ED, Frese AJ, Moore SJ, Greenlee JJ. Transmission of Raccoon-Passaged Chronic Wasting Disease Agent to White-Tailed Deer. Viruses 2022;14:1578. [DOI: 10.3390/v14071578] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Artikis E, Kraus A, Caughey B. Structural biology of ex vivo mammalian prions. J Biol Chem 2022;:102181. [PMID: 35752366 DOI: 10.1016/j.jbc.2022.102181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hannaoui S, Zemlyankina I, Chang SC, Arifin MI, Béringue V, Mckenzie D, Schatzl HM, Gilch S. Transmission of Cervid prions to Humanized Mice Demonstrates the Zoonotic Potential of CWD.. [DOI: 10.1101/2022.04.19.488833] [Reference Citation Analysis]
11 Mathiason CK. Large animal models for chronic wasting disease. Cell Tissue Res 2022. [PMID: 35113219 DOI: 10.1007/s00441-022-03590-4] [Reference Citation Analysis]
12 Hannaoui S, Zemlyankina I, Chang SC, Arifin MI, Béringue V, McKenzie D, Schatzl HM, Gilch S. Transmission of cervid prions to humanized mice demonstrates the zoonotic potential of CWD. Acta Neuropathol 2022;144:767-84. [PMID: 35996016 DOI: 10.1007/s00401-022-02482-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Brent Race, Chase Baune, Katie Williams, James F. Striebel, Andrew G. Hughson, Bruce Chesebro. Second passage experiments of chronic wasting disease in transgenic mice overexpressing human prion protein. Vet Res 2022;53:111. [PMID: 36527166 DOI: 10.1186/s13567-022-01130-0] [Reference Citation Analysis]